Correlation Between InMed Pharmaceuticals and Phio Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMed Pharmaceuticals and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on InMed Pharmaceuticals and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Phio Pharmaceuticals.

Diversification Opportunities for InMed Pharmaceuticals and Phio Pharmaceuticals

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between InMed and Phio is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between InMed Pharmaceuticals and Phio Pharmaceuticals

Considering the 90-day investment horizon InMed Pharmaceuticals is expected to generate 2.23 times more return on investment than Phio Pharmaceuticals. However, InMed Pharmaceuticals is 2.23 times more volatile than Phio Pharmaceuticals Corp. It trades about 0.02 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.04 per unit of risk. If you would invest  766.00  in InMed Pharmaceuticals on September 2, 2024 and sell it today you would lose (337.00) from holding InMed Pharmaceuticals or give up 43.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

InMed Pharmaceuticals  vs.  Phio Pharmaceuticals Corp

 Performance 
       Timeline  
InMed Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days InMed Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

InMed Pharmaceuticals and Phio Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with InMed Pharmaceuticals and Phio Pharmaceuticals

The main advantage of trading using opposite InMed Pharmaceuticals and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.
The idea behind InMed Pharmaceuticals and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets